Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cancer Gene Therapy - New cancer gene therapy research from University of Pittsburgh outlined
Cancer Vaccines - Scientists at University of Berlin release new data on cancer vaccines
Cancer Vaccines - Study data from C. Dulsat and co-authors update knowledge of cancer vaccines
Diarrhea - Patients with early Parkinsons disease experienced better symptom control and improvements in daily activities with Stalevo® than carbidopa/levodopa, according to study
Human Papillomavirus - Data from P. Lenzi and colleagues advance knowledge in human papillomavirus
Human Papillomavirus - Study results from University of Michigan broaden understanding of human papillomavirus
Immunotherapy - New immunotherapy study findings have been reported from Radboud University
Cancer Vaccines - Data on cancer vaccines described by researchers at New York University, Cancer Institute
Cancer Vaccines - Data on cancer vaccines published by researchers at University of Nijmegen
Cancer Vaccines - Data on cancer vaccines reported by researchers at Merck & Company, Inc.
Gene Therapy - Scientists at Fujian Medical University, Department of Hematology discuss research in gene therapy
Immunization - New immunization study findings reported from University of Milan, Department of Public Health
Cancer Vaccines - MabVax Therapeutics Receives Two Small Business Technology Transfer Program Awards From the National Cancer Institute
Cancer Vaccines - Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon
Merck & Co., Inc. - Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® raltegravir in Adult Patients Previously Untreated for HIV-1
